Second-line treatment for faecal incontinence

C.G.M.I. Baeten*, Ö Uludag

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Second-line treatment for faecal incontinence.

Baeten CG, Uludag O.

Dept. of Surgery, Academic Hospital Maastricht, The Netherlands.

BACKGROUND: In the treatment of faecal incontinence, more than 30% of patients experience continuation of their problem. We discuss new therapeutic procedures for dealing with faecal incontinence. METHODS: Discussion of authors' own work in relation to the literature. RESULTS: First-line care includes diets, constipating drugs, biofeedback therapy, anal repair and operations for prolapse and fistulas. For the failures of these first-line treatments there is hope with second-line therapies. Creation of a neosphincter is possible with a dynamic graciloplasty (DGP) or an artificial bowel sphincter (ABS). A DGP is a conventional graciloplasty with the addition of implanted electrodes and a stimulator that transforms the muscle into an automatic contracting sphincter. ABS comprises an inflatable cuff around the anus that is filled from a pressure-regulating balloon. The cuff can be emptied with an implanted pump. CONCLUSIONS: DGP and ABS give good results in 56%-88% of cases. For patients with an anatomical intact but nonfunctioning sphincter there is a new treatment: sacral nerve stimulation. This gives continence in a high percentage of cases, but experience is rather limited. Second-line treatment for faecal incontinence is successful and should be considered in cases where initial therapies fail.
Original languageEnglish
Pages (from-to)72-75
Number of pages4
JournalScandinavian Journal of Gastroenterology
VolumeSuppl 236
Publication statusPublished - 1 Jan 2002


Dive into the research topics of 'Second-line treatment for faecal incontinence'. Together they form a unique fingerprint.

Cite this